WHO ICTRP trial
Efficacy and Safety of Thalidomide Combined with Cyclosporine in the Treatment…
ChiCTR-OIC-17012860 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-OIC-17012860 |
|---|---|
| Public title | Efficacy and Safety of Thalidomide Combined with Cyclosporine in the Treatment of Corticosteroid-resistant or Relapsed ITP: a Single Arm Clinical Study |
| Scientific title | Efficacy and Safety of Thalidomide Combined with Cyclosporine in the Treatment of Corticosteroid-resistant or Relapsed ITP: a Single Arm Clinical Study |
| Primary sponsor | Affiliated Hospital of Guangdong Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | II (Phase II study) |
| Countries | China |
| Conditions | Immune Thrombocytopenia |
| Interventions | Case series:Thalidomide + Cyclosporine |
| Registration date | Oct 1, 2017 |
| Target size | Case series:33 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: